At a Glance Computational modeling & simulation is another tool in the engineer's testing toolbox, says MD&M West speaker Mark Burchnall. MD&M West will be held February 4-6, 2025. Burchnall, an ...

The firm is touting its AI-driven foundation model's ability to predict how any patient will respond to any drug, allowing sponsors to fine-tune their trials.

Certara the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced that its Simcyp physiologically-based pharmacokinetic (PBPK) ...

Detailed price information for Adial Pharmaceuticals Inc (ADIL-Q) from The Globe and Mail including charting and trades.

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables Nov. 13, 2024 8:30 AM ET Simulations Plus, Inc. (SLP) ...

Study in a Sentence: A new multi-component, transformer-based, open-source AI model, Boltz-2, predicts protein–drug binding ...

Simulations Plus has been serving clients globally for over 25 years, offering software and consulting services that span across various modeling approaches in drug discovery and development.

NEW YORK, May 09, 2025--QuantHealth, an AI-powered clinical trial simulation company, today unveiled its Large Real-World Drug Model (LRDM v1.0), a first-of-its-kind clinical trial foundation ...

Detailed price information for Simulations Plus Inc (SLP-Q) from The Globe and Mail including charting and trades.

Certara today announced the launch of its industry-leading Phoenix 8.0 PK/PD modeling and simulation software for drug development scientists.